Brellium’s Big Bet on Clinical Compliance—And Why It Matters for ABA
Most startup funding announcements sound alike—big numbers, bold promises, broad markets. But Brellium’s recent $16.7M Series A, led by First Round Capital, is something different.
They’re not chasing the latest hype cycle. They’re going after a deeply unsexy, high-stakes problem that affects every healthcare provider